EP4139362 - PD-1 AGONIST MULTIMERIC BINDING MOLECULES [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 27.01.2023 Database last updated on 13.11.2024 | |
Former | The international publication has been made Status updated on 29.10.2021 | Most recent event Tooltip | 05.06.2024 | New entry: Additional fee for renewal fee: despatch of communication + time limit | Applicant(s) | For all designated states IGM Biosciences Inc. 325 E. Middlefield Road Mountain View, CA 94043 / US | [2023/09] | Inventor(s) | 01 /
KEYT, Bruce IGM Biosciences, Inc. 325 East Middlefield Road Mountain View, California 94043 / US | 02 /
METZGER, Todd IGM Biosciences, Inc. 325 East Middlefield Road Mountain View, California 94043 / US | 03 /
SINCLAIR, Angus IGM Biosciences, Inc. 325 East Middlefield Road Mountain View, California 94043 / US | [2023/09] | Representative(s) | Inspicos P/S Agern Allé 24 2970 Hørsholm / DK | [2023/09] | Application number, filing date | 21792296.2 | 21.04.2021 | [2023/09] | WO2021US28459 | Priority number, date | US202063014023P | 22.04.2020 Original published format: US 202063014023 P | US202063050413P | 10.07.2020 Original published format: US 202063050413 P | US202163144708P | 02.02.2021 Original published format: US 202163144708 P | [2023/09] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2021216756 | Date: | 28.10.2021 | Language: | EN | [2021/43] | Type: | A2 Application without search report | No.: | EP4139362 | Date: | 01.03.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.10.2021 takes the place of the publication of the European patent application. | [2023/09] | Search report(s) | International search report - published on: | US | 02.12.2021 | Classification | IPC: | C07K16/28, A61K39/395, A61P29/00, A61P37/04, A61P37/06 | [2024/17] | CPC: |
C07K16/2818 (EP,IL,KR,US);
A61P37/00 (KR);
A61P37/06 (EP);
A61K2039/505 (KR);
C07K2317/35 (EP,IL,KR,US);
C07K2317/52 (EP,US);
C07K2317/565 (US);
C07K2317/75 (EP,IL,KR,US);
C07K2317/92 (EP,IL,KR,US);
C07K2317/94 (EP,US)
(-)
|
Former IPC [2023/09] | C07K16/28, A61P29/00, A61K39/00, A61P37/04 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/09] | Title | German: | MULTIMERE PD-1-AGONIST-BINDUNGSMOLEKÜLE | [2023/09] | English: | PD-1 AGONIST MULTIMERIC BINDING MOLECULES | [2023/09] | French: | MOLÉCULES DE LIAISON MULTIMÈRES AGONISTES DE PD-1 | [2023/09] | Entry into regional phase | 22.11.2022 | National basic fee paid | 22.11.2022 | Search fee paid | 22.11.2022 | Designation fee(s) paid | 22.11.2022 | Examination fee paid | Examination procedure | 22.11.2022 | Examination requested [2023/09] | 26.05.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 20.04.2023 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 30.04.2024 | 04   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]US2007154469 (IRIE REIKO [JP]); | [Y]WO2011110604 (UCB PHARMA SA [BE], et al); | [YYY]WO2018017889 (IGM BIOSCIENCES INC [US]); | [YY]US2019270818 (YACHI PIA PAULIINA [US], et al); | [Y]WO2019169314 (IGM BIOSCIENCES INC [US]); | [PXPXP]WO2020086745 (IGM BIOSCIENCES INC [US]); | by applicant | US4683195 | US5585089 | US5693761 | US5693762 | US5892019 | US5939598 | US6180370 | WO2017196867 | US2018009897 | US9938347 | US9951134 | US2018118816 | US2018118814 | US2018265596 | WO2018187702 | US2019002566 | US2019100597 | US2019185570 | US10351631 | WO2019165340 | US10400038 | WO2019169314 | US2019330374 | US2019330360 | US2019338040 | US2019338041 | US19630628912 | WO2019US57702 |